WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer
Supplementary Data
- Supplementary Table 1 - data from TCGA measuring the incidence of CNA or mutation of the 48 nuclear receptors (NR) in prostate cancer samples. (PDF 93 KB)
This Article
-
Endocr Relat Cancer November 1, 2016 vol. 23 no. 11 T85-T108
- AbstractFree
- Figures Only
- Full Text
- Full Text (PDF)
- Supplementary Data
Most
-
Viewed
- Progesterone metabolites in breast cancer
- Association of Hashimoto's thyroiditis with thyroid cancer
- The emerging roles of DNA methylation in the clinical management of prostate cancer
- Lipomatous tumours in adrenal gland: WHO updates and clinical implications
- Design and validation of specific inhibitors of 17{beta}-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis
-
Cited
- Fibroblast growth factors, their receptors and signaling
- The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
- BRAF mutation in thyroid cancer
- mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
- Diabetes and cancer
